Atea Pharmaceuticals, Inc. — Director's Dealing 2020

Oct 30, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Atea Pharmaceuticals, Inc. (AVIR)
CIK: 0001593899
Period of Report: 2020-10-29

Reporting Person: Duncan Barbara Gayle (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-29	Stock Option (Right to Buy)	$24.00	A	80000	Acquired	2030-10-28	Common Stock (80000)	Direct

Footnotes

F1: The option vests and becomes exercisable in 36 equal monthly installments following October 29, 2020.